89 related articles for article (PubMed ID: 38306344)
1. Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects.
Sinkala M; Naran K; Ramamurthy D; Mungra N; Dzobo K; Martin D; Barth S
PLoS One; 2024; 19(2):e0296511. PubMed ID: 38306344
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
3. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC
Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269
[TBL] [Abstract][Full Text] [Related]
4. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
5. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.
Jiang WG; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE; Fodstad O
Int J Cancer; 2005 Dec; 117(5):730-7. PubMed ID: 15957166
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of cancer-driver genes across human cancers.
Sinkala M
Sci Rep; 2023 Aug; 13(1):12742. PubMed ID: 37550388
[TBL] [Abstract][Full Text] [Related]
8. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.
Pradat Y; Viot J; Yurchenko AA; Gunbin K; Cerbone L; Deloger M; Grisay G; Verlingue L; Scott V; Padioleau I; Panunzi L; Michiels S; Hollebecque A; Jules-Clément G; Mezquita L; Lainé A; Loriot Y; Besse B; Friboulet L; André F; Cournède PH; Gautheret D; Nikolaev SI
Cancer Discov; 2023 May; 13(5):1116-1143. PubMed ID: 36862804
[TBL] [Abstract][Full Text] [Related]
9. Pharos 2023: an integrated resource for the understudied human proteome.
Kelleher KJ; Sheils TK; Mathias SL; Yang JJ; Metzger VT; Siramshetty VB; Nguyen DT; Jensen LJ; Vidović D; Schürer SC; Holmes J; Sharma KR; Pillai A; Bologa CG; Edwards JS; Mathé EA; Oprea TI
Nucleic Acids Res; 2023 Jan; 51(D1):D1405-D1416. PubMed ID: 36624666
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
Roelands J; van der Ploeg M; Ijsselsteijn ME; Dang H; Boonstra JJ; Hardwick JCH; Hawinkels LJAC; Morreau H; de Miranda NFCC
Gut; 2023 Jul; 72(7):1326-1339. PubMed ID: 36442992
[TBL] [Abstract][Full Text] [Related]
11. AI-Assisted QT Measurements for Highly Automated Drug Safety Studies.
Diaw MD; Papelier S; Durand-Salmon A; Felblinger J; Oster J
IEEE Trans Biomed Eng; 2023 May; 70(5):1504-1515. PubMed ID: 36355743
[TBL] [Abstract][Full Text] [Related]
12. EGFR as a potent CAR T target in triple negative breast cancer brain metastases.
Subham S; Jeppson JD; Worcester C; Schatmeyer B; Zhao J; Madan R; Lakis NS; Kimler BF; McGuirk JP; Chen RC; Stecklein SR; Akhavan D
Breast Cancer Res Treat; 2023 Jan; 197(1):57-69. PubMed ID: 36318382
[TBL] [Abstract][Full Text] [Related]
13. Automated Model Inference for Gaussian Processes: An Overview of State-of-the-Art Methods and Algorithms.
Berns F; Hüwel J; Beecks C
SN Comput Sci; 2022; 3(4):300. PubMed ID: 35647556
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
